Aihua Wu gave a talk “Thiazide Treatment Effects on NCC Abundance and Phosphorylation in 2 FHHt Patients.” at the 55th Online Annual Scientific Meeting of the Australia and New Zealand Society of Nephrology, 30 November- 2 December, 2020.

/0 Comments/in , , /by

The Cl−/HCO3− exchanger pendrin is downregulated during oral co-administration of exogenous mineralocorticoid and KCl in patients with primary aldosteronism

/in , , /by

, , , ,  &  Journal of Human Hypertension (2020)

Effects of Ramipril on the Aldosterone/Renin Ratio and the Aldosterone/Angiotensin II Ratio in Patients With Primary Aldosteronism

/in /by

Guo Z, Poglitsch M, Cowley D, Domenig O, McWhinney BC, Ungerer JPJ, Wolley M, Stowasser M. Hypertension. 2020 Jun 8:HYPERTENSIONAHA12014871. doi: 10.1161/HYPERTENSIONAHA.120.14871. Online ahead of print. PMID: 32507039

Diagnosis of Primary Aldosteronism by Seated Saline Suppression Test-Variability Between Immunoassay and HPLC-MS/M

/in /by

Thuzar M, Young K, Ahmed AH, Ward G, Wolley M, Guo Z, Gordon RD, McWhinney BC, Ungerer JP, Stowasser M. J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz150. doi: 10.1210/clinem/dgz150. PMID: 31676899

Controversies and advances in adrenal venous sampling in the diagnostic workup of primary aldosteronis

/in /by

Wolley M, Thuzar M, Stowasser M. Best Pract Res Clin Endocrinol Metab. 2020 Feb 22:101400. doi: 10.1016/j.beem.2020.101400. Online ahead of print. PMID: 32115358 Review.

The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway

/in /by

Wu A, Wolley M, Stowasser M. J Hum Hypertens. 2019 Jul;33(7):508-523. doi: 10.1038/s41371-019-0170-6. Epub 2019 Feb 5. PMID: 30723251

Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels

/in /by

Stowasser M, Wolley M, Wu A, Gordon RD, Schewe J, Stölting G, Scholl UI. Curr Hypertens Rep. 2019 Apr 4;21(4):31. doi: 10.1007/s11906-019-0934-y. PMID: 30949771 Review.

Comparison of Seated With Recumbent Saline Suppression Testing for the Diagnosis of Primary Aldosteronism

/in /by

Stowasser M, Ahmed AH, Cowley D, Wolley M, Guo Z, McWhinney BC, Ungerer JP, Gordon RD. J Clin Endocrinol Metab. 2018 Nov 1;103(11):4113-4124. doi: 10.1210/jc.2018-01394. PMID: 30239841Wilson PC, Wu H, Kirita Y, Uchimura K, Ledru N, Rennke HG, Welling PA, Waikar SS, Humphreys BD. Proc Natl Acad Sci U S A. 2019 Sep 24;116(39):19619-19625. doi: 10.1073/pnas.1908706116. Epub 2019 Sep 10. PMID: 31506348

CLCN2 chloride channel mutations in familial hyperaldosteronism type II

/in /by

Scholl UI, Stölting G, Schewe J, Thiel A, Tan H, Nelson-Williams C, Vichot AA, Jin SC, Loring E, Untiet V, Yoo T, Choi J, Xu S, Wu A, Kirchner M, Mertins P, Rump LC, Onder AM, Gamble C, McKenney D, Lash RW, Jones DP, Chune G, Gagliardi P, Choi M, Gordon R, Stowasser M, Fahlke C, Lifton RP. Nat Genet. 2018 Mar;50(3):349-354. doi: 10.1038/s41588-018-0048-5. Epub 2018 Feb 5. PMID: 29403011

Cellular and Genetic Causes of Idiopathic Hyperaldosteronism

/in /by

Omata K, Satoh F, Morimoto R, Ito S, Yamazaki Y, Nakamura Y, Anand SK, Guo Z, Stowasser M, Sasano H, Tomlins SA, Rainey WE. Hypertension. 2018 Oct;72(4):874-880. doi: 10.1161/HYPERTENSIONAHA.118.11086. PMID: 30354720